Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
11:55:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 193.50 EUR | -0.77% |
|
+4.31% | -7.86% |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| 08-20 | European stock markets slip as oil prices surge again |  |
| Market Cap | 18.83B 21.98B 17.62B 16.13B 30.26B 2,103B 30.66B 208B 81.16B 1,056B 82.53B 80.73B 3,494B | P/E 2026 * |
49.6x | P/E 2027 * | 38.5x |
|---|---|---|---|---|---|
| Enterprise Value | 20.84B 24.32B 19.5B 17.85B 33.49B 2,327B 33.94B 230B 89.83B 1,169B 91.34B 89.35B 3,867B | EV / Sales 2026 * |
6.67x | EV / Sales 2027 * | 5.94x |
| Free-Float |
28.47% | Yield 2026 * |
0.43% | Yield 2027 * | 0.52% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -0.77% | ||
| 1 week | +4.31% | ||
| Current month | +16.08% | ||
| 1 month | +10.38% | ||
| 3 months | +13.36% | ||
| 6 months | +5.88% | ||
| Current year | -7.86% |
| 1 week | 178.3 |  | 195.5 |
| 1 month | 160.8 | | 195.5 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | +4.31% | +8.80% | -22.10% | 21.98B | |
| +2.19% | +4.84% | -12.03% | +10.93% | 202B | |
| +1.14% | +2.28% | +0.69% | +11.50% | 119B | |
| +1.06% | +1.34% | +8.69% | +78.71% | 60.69B | |
| -1.37% | -6.57% | +30.31% | +55.01% | 52.38B | |
| +2.33% | +4.69% | -3.84% | -30.36% | 52.3B | |
| +2.35% | +2.89% | +12.25% | -13.68% | 34.85B | |
| +5.16% | -4.14% | - | - | 30.06B | |
| -0.20% | +1.05% | +42.46% | -10.20% | 24.85B | |
| -0.29% | -3.87% | -6.19% | +25.59% | 23.84B | |
| Average | +1.16% | +0.68% | +9.02% | +11.71% | 62.23B | |
| Weighted average by Cap. | +1.45% | +1.99% | +1.85% | +15.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.65B 2.93B 2.68B 5.03B 349B 5.09B 34.56B 13.48B 175B 13.7B 13.41B 580B | 3.47B 4.05B 3.24B 2.97B 5.57B 387B 5.65B 38.34B 14.95B 195B 15.2B 14.87B 644B |
| Net income | 379M 443M 355M 325M 609M 42.34B 617M 4.19B 1.63B 21.27B 1.66B 1.63B 70.35B | 481M 561M 450M 412M 773M 53.72B 783M 5.32B 2.07B 26.99B 2.11B 2.06B 89.26B |
| Net Debt | 2.01B 2.35B 1.88B 1.72B 3.23B 224B 3.27B 22.22B 8.66B 113B 8.81B 8.62B 373B | 1.76B 2.06B 1.65B 1.51B 2.83B 197B 2.87B 19.47B 7.59B 98.82B 7.72B 7.55B 327B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €193.50 | -0.77% | 77,268 |
| 26-08-20 | €195.00 | +6.62% | 114,532 |
| 26-08-19 | €182.90 | +1.33% | 68,969 |
| 26-08-18 | €180.50 | -0.61% | 74,496 |
| 26-08-17 | €181.60 | -2.10% | 91,334 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
